Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial PMID: 37385280 Lancet
We know how complex obesity and obesogenic environments are, and efforts to address obesity should not prioritize medications but rather consider the complex holistic and systemic changes in health environments, lifestyle factors, etc, to derive more sustainable benefits. Careful patient selection is also critical
Energieverbruik, vetstofwisseling en insulineregulatie
Additionally, avoid Zepbound if you are allergic to tirzepatide
We suggest that patients on HGH therapy have their blood glucose checked often
It prescribes compounded semaglutide and tirzepatide for weight loss through an online consultation model